Related Experiment Videos

Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys

N Hayase1, K Tomiyoshi, K Watanabe

  • 1Department of Neurosurgery and Nuclear Medicine, Gunma University School of Medicine, Japan.

Insights

4-[18F]fluoro-L-m-tyrosine (FMT) positron emission tomography (PET) effectively detects dopaminergic terminals. FMT uptake reduction in hemiparkinsonian monkeys indicates its potential for evaluating parkinsonism.

Area of Science:

  • Neuroscience
  • Radiochemistry
  • Medical Imaging

Background:

  • Parkinsonism is a neurodegenerative disorder affecting dopaminergic systems.
  • Accurate assessment of dopaminergic terminal integrity is crucial for diagnosis and treatment monitoring.
  • Positron Emission Tomography (PET) offers a non-invasive method for in vivo imaging of neurochemical processes.

Purpose of the Study:

  • To evaluate 4-[18F]fluoro-L-m-tyrosine (FMT) as a PET tracer for assessing central dopaminergic systems.
  • To investigate FMT uptake in normal and hemiparkinsonian primate models.
  • To determine the correlation between FMT uptake and aromatic L-amino acid decarboxylase (AAAD) activity.

Main Methods:

  • PET imaging was performed in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian macaca monkeys.
  • Radioactivity accumulation of FMT was measured over time in the striatum.
  • AAAD activity was assessed in relation to FMT uptake in lesioned and normal striata.

Main Results:

  • Selective accumulation of FMT radioactivity was observed in the striatum of normal monkeys.
  • FMT uptake was significantly reduced in the MPTP-lesioned striatum of hemiparkinsonian monkeys.
  • FMT-PET studies demonstrated reduced AAAD activities in the MPTP-lesioned striatum, correlating with dopaminergic terminal loss.

Conclusions:

  • FMT is a promising PET tracer for visualizing and quantifying central dopaminergic terminals.
  • FMT-PET imaging can effectively detect alterations in dopaminergic systems characteristic of parkinsonism.
  • This tracer holds potential for evaluating the efficacy of therapies targeting parkinsonism.

Related Concept Videos